**Core Concept**
Advanced Proliferative Diabetic Retinopathy (PDR) is a complication of diabetes mellitus characterized by the growth of new, fragile blood vessels in the retina. These new vessels can lead to extensive vitreoretinal fibrosis and tractional retinal detachment, causing vision loss. Treatment aims to reduce vitreous traction, remove blood and fibrovascular tissue, and flatten the retina.

**Why the Correct Answer is Right**
Treatment of advanced PDR involves surgical intervention, specifically vitreoretinal surgery. Pars plana vitrectomy (PPV) is the standard surgical approach, where the vitreous gel is removed, along with any blood and fibrovascular tissue. This procedure helps to reduce vitreous traction, flatten the retina, and improve vision. Panretinal photocoagulation (PRP) may also be performed to reduce ischemic drive for neovascularization.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the treatment of advanced PDR with extensive vitreoretinal fibrosis and tractional retinal detachment.
**Option B:** This option might be relevant in treating diabetic retinopathy but is not the primary treatment for advanced PDR with extensive vitreoretinal fibrosis and tractional retinal detachment.
**Option C:** This option is also not the primary treatment for advanced PDR with extensive vitreoretinal fibrosis and tractional retinal detachment.
**Option D:** This option is not directly related to the treatment of advanced PDR with extensive vitreoretinal fibrosis and tractional retinal detachment.

**Clinical Pearl / High-Yield Fact**
When managing advanced PDR, it's essential to note that the goal of treatment is to reduce ischemic drive for neovascularization and alleviate vitreous traction. Panretinal photocoagulation (PRP) can be an effective adjunct therapy to reduce ischemic drive, but it's not a substitute for surgical intervention.

**Correct Answer: D.**